21.04.2022 - BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-driven biotechnology company focused on developing innovative and affordable medicines, and Crossroads4Hope, A Network of Cancer Support, a 501(c)(3) organization committed to .
Item 2.02 Results of Operations and Financial Condition
On January 10, 2022, Passage Bio, Inc. will present a corporate
presentation at the J.P. Morgan 40th Annual Healthcare
Conference , which. | January 10, 2022